Contemporary and Future Strategies in Myelofibrosis: Applying New Evidence to Personalize Care

Get up to date on contemporary management of myelofibrosis with expert commentaries, downloadable slides, and an on-demand webcast from a live symposium.

Share

Program Content

Activities

First-line MF Treatment
Selection of Initial Treatment for Patients With Myelofibrosis
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2023

Practical Concepts in MF Treatment
Practical Concepts and Defining Failure to First-line MF Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2023

JAK Inhibitor Failure
Therapeutic Landscape for Patients With MF and JAK Inhibitor Failure
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2023

Activities

Contemporary and Future Strategies in Myelofibrosis
Contemporary and Future Strategies in Myelofibrosis: Applying New Evidence to Personalize Care
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 21, 2023

Expires: June 20, 2024

Activities

FAQs: Treating Myelofibrosis
Rapid-fire Answers to Key Questions in Treating Myelofibrosis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 24, 2023

Faculty

cover img faculity

John Mascarenhas, MD

Director, Adult Leukemia Program
Leader, Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute 
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

cover img faculity

Ruben A. Mesa, MD

President
Enterprise Cancer Service Line
Executive Director
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Enterprise Senior Vice President
Atrium Health
Vice Dean for Cancer Programs
Wake Forest University School of Medicine
Professor of Medicine
Wake Forest University School of Medicine
Winston-Salem, North Carolina

cover img faculity

Brady L. Stein, MD, MHS

Professor of Medicine
Department of Hematology/Oncology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AbbVie, Inc., CTI BioPharma, GSK, and Incyte Corporation.

AbbVie, Inc.

CTI BioPharma

GSK

Incyte Corporation